• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Shanghai Sunway Biotech Co. Ltd.

Headquarters: Shanghai, China
Year Founded: 1995
Status: Private

BioCentury | Nov 18, 2022
Product Development

Oncolytic virus combinations move beyond checkpoint inhibitors

SITC updates suggest the next wave of oncolytic viruses will be paired with bispecifics, cell therapies
BioCentury | Nov 16, 2021
Data Byte

The oncolytic virus pipeline

At least 49 oncolytic virus therapies now in development behind the sole FDA-approved product
BioCentury | Sep 15, 2017
Company News

China Resources invests in Converd

BioCentury | Sep 13, 2017
Company News

China Resources invests in Converd

BioCentury | Feb 29, 2016
Product Development

Infectious enthusiasm

How oncolytic viruses are coming of age in cancer immunotherapy combinations
BioCentury | Jan 31, 2011
Strategy

Lysing what it sees

Amgen buying BioVex for OncoVEX immunotherapy based on Phase II melanoma data
BioCentury | Feb 8, 2010
Product Development

Checking the boxes in gene therapy

BioCentury | May 14, 2009
Distillery Therapeutics

Indication: Cancer

BioCentury | Sep 18, 2008
Cover Story

Dismantling cancer's immune defense

Items per page:
1 - 10 of 12